Background: Neuromyelitis optica (NMO) is a demyelinating disorder involving optic neuritis and transverse myelitis.
The antibody suspension bead array technology has been shown to be highly applicable for discovery of potential biomarkers in blood derived samples [1]. For analysis in neurodegenerative disorders like multiple sclerosis (MS), cerebrospinal fluid (CSF) is another highly interesting body fluid for protein profiling efforts [2].
Background: Neuromyelitis optica (NMO) is characterized by severe optic neuritis and transverse myelitis. Aquaporin-4 (AQP4) antibody is a diagnostic biomarker of NMO
May 5, 2010 — Devic’s neuromyelitis optica (DNMO) is a demyelinating disease characterized by bilateral visual disturbance and transverse myelopathy. It was first described in 1894 by Eugene Devic [1] in a woman who suffered from a bilateral optic neuritis and acute transverse myelitis. Pathologically, lesions are restricted to the optic nerves and spinal cord, with areas of necrosis of gray and white matter, cavitations, lack of inflammatory infiltrate, vascular hyalinization, and fibrosis [2]
Background: Neuromyelitis optica (NMO) is assumed to be immunologically distinct from multiple sclerosis (MS). Adequate studies about cytokines and chemokines in NMO have been lacking.Objective: To investigate the contribution of cytokines/chemokines in the pathogenesis of NMO.Methods: We measured 27 cytokines/chemokines and Th17 cell-associated cytokines in the cerebrospinal fluid (CSF) of 31 NMO, 29 MS and 18 other non-inflammatory neurological disorders patients. The serum levels of some cytokines/chemokines were also measured.